NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
Clin Sci (Lond). 2014 Feb;126(3):233-41. doi: 10.1042/CS20130043.
Clin Sci (Lond). 2014.
PMID: 23944632
Clinical Trial.